Search Results 41-50 of 5438 for edward loftus

  1. Dr. William Young Archives - Mayo Clinic News Network

    ... Edward Loftus Jr. Also on the program, endocrinologist Dr. William Young Jr. explains why the pituitary gland is known as the “master gland," and ...

  2. Contact - Irritable Bowel Syndrome Lab: Yuri A. Saito-Loftus - Mayo Clinic Research

    Contact information for Dr. Saito Loftus' Irritable Bowel Syndrome Laboratory at Mayo Clinic's campus in Minnesota.

  3. A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC) - Mayo Clinic

    Edward Loftus, M.D.. Contact information: Troy Ofstie R.N., CCRP. (507) 266-4728. Contact UsIBDresearch@mayo.edu. Contact us for the latest status. More ...

  4. Focus Areas - Irritable Bowel Syndrome Lab: Yuri A. Saito-Loftus - Mayo Clinic Research

    Dr. Saito Loftus' Irritable Bowel Syndrome Lab at Mayo Clinic studies epidemiology and genetic, environmental and familial contributors to GI disorders.

  5. A Study to Evaluate the Long-Term Effectiveness, Safety, and Tolerability of Repeated Administration of ABT-494 in Patients with Crohn's Disease - Mayo Clinic

    Edward Loftus, M.D.. Contact information: IBD Clinical Research Unit. (507) 284-5908. Closed for enrollment. More information. Publications. Publications are ...

  6. Mayo doctor reflects on 2 years of COVID-19

    It's clearly the best way of preventing serious illness, hospitalization, ICU admissions and decompressing our hospitals," says Dr. Conor Loftus, chair of Mayo ...

  7. Dr. Conor Loftus Archives - Mayo Clinic News Network

    ... Loftus, M.D./Chair, Outpatient Practice/Mayo Clinic. Like many hospitals across the country, Mayo Clinic continues to operate at nearly full capacity. Many ...

  8. A Study Comparing the Long Term Safety of Entyvio (Vedolizumab) to Other Biologic Agents in Patients with Ulcerative Colitis or Crohn's Disease - Mayo Clinic

    Participating Mayo Clinic locations ; Rochester, Minn. Mayo Clinic principal investigator. Edward Loftus, M.D.. Closed for enrollment ...

  9. Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects with Moderate to Severe Crohn's Disease - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  10. A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI) - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...